Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Amphastar Pharmaceuticals Inc (AMPH) vs Cipher Mining Inc (CIFR) Price & Performance

Amphastar Pharmaceuticals Inc
Cipher Mining Inc

Price performance

Price movement over the last 24 hours

Key statistics

Amphastar Pharmaceuticals Inc vs Cipher Mining Inc — how do they compare? Amphastar Pharmaceuticals Inc trades at $18.72 (market cap $826.08M), while Cipher Mining Inc trades at $21.71 (market cap $9.04B). The key difference: Cipher Mining Inc is far larger — about 10.9× Amphastar Pharmaceuticals Inc's market cap, and Cipher Mining Inc is trading nearer its 52-week high, Amphastar Pharmaceuticals Inc nearer its low. Which is the better fit depends on your goals.

AMPHCIFR
Market Cap
$826.08M$9.04B
Sector
HealthBasic Materials
52-Week High
$30.81$29.18
52-Week Low
$16.87$4.72
Enterprise Value
$1.22B$13.07B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Amphastar Pharmaceuticals Inc

AMPH trades at $18.72, down 1.58% with bearish technical signals despite oversold RSI readings. The company reported mixed Q1 2026 results with EPS of $0.42 missing estimates of $0.70, continuing a trend of recent earnings disappointments. Valuation metrics appear reasonable with P/E of 11.29 and P/B of 1.07, while profitability remains solid with 47.34% gross margins. Recent news includes a Zacks Strong Sell rating and ongoing securities law investigation.

The stock faces near-term headwinds from earnings misses and negative analyst sentiment, though current valuations provide some downside protection. Upside potential exists if the company can execute its strategic pivot to proprietary drugs and biosimilars while managing BAQSIMI discount pressures. Key risks include ongoing legal scrutiny and competitive pressures in the generic drug market.

Cipher Mining Inc

Cipher Digital (CIFR) trades at $22.11, down 4.94% today, amid a transition from Bitcoin mining to AI data center operations. The stock shows a bullish technical trend with strong analyst support (100% buy ratings) and a $32.81 consensus price target. However, fundamentals reveal deep losses with a -427.79% net income margin and negative cash flow from operations, offset by a promising $11.4B contracted revenue backlog from hyperscale leases.

The outlook hinges on successful execution of its AI infrastructure pivot, offering substantial upside if revenue ramps as planned by 2027. Key risks include persistent cash burn, high debt-to-asset ratio (64.51%), and reliance on future lease performance. Investors should weigh the growth potential against the company's current financial instability.

Returns comparison

Trailing returns across standard periods

About Amphastar Pharmaceuticals Inc

Amphastar is a specialty pharmaceutical company that develops and markets injectable, intranasal, and inhalation products. Its portfolio includes both complex generic drugs and proprietary delivery systems.

Read more on AMPH

About Cipher Mining Inc

Cipher Mining is an industrial-scale technology company focused on Bitcoin mining infrastructure. It develops and operates data centers in the US designed to strengthen the Bitcoin network and support decentralized finance.

Read more on CIFR